As announced previously, providers should not be submitting original claims for home health services using Bill Type 33X. Effective immediately, providers should use Bill Type 32X or 34X.
Effective July 1, 2020, End Stage Renal Disease Treatment providers (261QE0700X) were added to the list of eligible providers for Procedure Code J0887, Mircera Injection, Epoetin Beta, 1 Microgram.
This bulletin provides important information regarding changes in the law concerning connection deadlines to NC HealthConnex, the state-designated health information exchange. It also describes a “Hardship Extension Process” coordinated by DHHS.
Following the Oct. 30, 2020, announcement that the NCTracks secure portal is live, providers are encouraged to submit qualifying COVID-19 related primary care services claims for reimbursement through the NCTracks secure portal.
For facilities using a point-of-care antigen test device for detection of SARS-CoV-2, this is a reminder that providers are required by State Health Director Order to report all results, positive and negative, of diagnostic testing for SARS-CoV-2, the virus that causes COVID-19.